FDA Grants Approval To AstraZeneca's New Lung Cancer Pill Medicine & Technology Nov 16, 2015 The Food and Drug Administration (FDA) recently approved a new lung cancer pill, called AZD9291 or Tagrisso, from AstraZeneca after its two-year clinical trial with promising results.
Project Hephaistos: Scientists Claim To Have Detected Technosignatures From Dyson Spheres of Alien Civilization
Kaymakli Underground City: A Maze of Tunnels Deep Beneath the Earth Where Ancient Turkish Lived for Centuries
Richest Man Who Ever Lived: Amenhotep III’s Face Revealed for the First Time Using Data From His Skull
Mauna Loa Observatory Reveals CO2 Accumulating in the Atmosphere Faster Than Ever; What Caused the Unexpected Pace of Global Warming?
SPACE James Webb Space Telescope Finds Most Distant Pair of Colliding Black Holes, Raising Questions Regarding Theories of Cosmology
SPACE Don Pettit, Oldest Active NASA Astronaut, Gears Up for New Mission to the International Space Station
SPACE Massive X8.7 Solar Flare From Super-Active Sunspot Causes Radio Blackouts Over North, South America Days After Widespread Aurora Displays